Cesarman-Maus et al. [59] raised the hypothesis that anti-ANXA2 autoantibodies may promote hypercoagulation and fibrin deposition by inhibiting t-PA-dependent plasmin formation. This evidence concerns the gene PLG and thrombophilia.